Preclinical Evaluation of Imaging Biomarkers for Prostate Cancer Bone Metastasis and Response to Cabozantinib
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Evaluation of Imaging Biomarkers for Prostate Cancer Bone Metastasis and Response to Cabozantinib
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 106, Issue 4, Pages -
Publisher
Oxford University Press (OUP)
Online
2014-03-15
DOI
10.1093/jnci/dju033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
- (2015) Anwar R. Padhani et al. NEOPLASIA
- The IGR-CaP1 Xenograft Model Recapitulates Mixed Osteolytic/Blastic Bone Lesions Observed in Metastatic Prostate Cancer
- (2015) Nader Al Nakouzi et al. NEOPLASIA
- Multimodality Imaging of Tumor and Bone Response in a Mouse Model of Bony Metastasis
- (2014) Benjamin A. Hoff et al. Translational Oncology
- Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
- (2012) David C. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- Bony metastases: assessing response to therapy with whole-body diffusion MRI
- (2012) A.R. Padhani et al. CANCER IMAGING
- Characterization of Bone Metastases from Rapid Autopsies of Prostate Cancer Patients
- (2011) R. Mehra et al. CLINICAL CANCER RESEARCH
- Assessing response in bone metastases in prostate cancer with diffusion weighted MRI
- (2011) C. Messiou et al. EUROPEAN RADIOLOGY
- Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility
- (2011) C. Messiou et al. EUROPEAN RADIOLOGY
- Emerging Therapies to Prevent Skeletal Morbidity in Men With Prostate Cancer
- (2011) Philip J. Saylor et al. JOURNAL OF CLINICAL ONCOLOGY
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- The Bone Scan
- (2011) Arnold I. Brenner et al. SEMINARS IN NUCLEAR MEDICINE
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- New molecular targets in bone metastases
- (2010) D. Santini et al. CANCER TREATMENT REVIEWS
- PSA as an intermediate end point in clinical trials
- (2009) Gerhardt Attard et al. Nature Reviews Urology
- Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study
- (2008) D. R. Berthold et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started